Boothbay Fund Management’s Amedisys AMED Stock Holding History

Boothbay Fund Management’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-3,950	Closed	-$366K	–	1430
2025 Q1	$366K	Buy	3,950 +1,735	+78%	+$160K	0.01%	979
2024 Q4	$201K	Sell	2,215 -46,330	-95%	-$4.25M	0.01%	1196
2024 Q3	$4.69M	Sell	48,545 -7,104	-13%	-$693K	0.11%	269
2024 Q2	$5.11M	Buy	55,649 +19,018	+52%	+$1.76M	0.12%	221
2024 Q1	$3.38M	Buy	+36,631	New	+$3.43M	0.07%	338
2023 Q2	–	Sell	-4,954	Closed	-$364K	–	1777
2023 Q1	$364K	Buy	+4,954	New	+$429K	0.01%	1412
2021 Q4	–	Sell	-1,892	Closed	-$282K	–	1835
2021 Q3	$282K	Buy	+1,892	New	+$393K	0.01%	1363
2019 Q4	–	Sell	-6,113	Closed	-$801K	–	837
2019 Q3	$801K	Buy	+6,113	New	+$796K	0.07%	357

Other funds holding AMED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

TAL

TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Boothbay Fund Management's AMED Position: Q2 2025 in Review

Boothbay Fund Management sold out of Amedisys (AMED) in Q2 2025, closing a stake of 3,950 shares — an estimated $366K sold.

Boothbay Fund Management first reported a position in AMED in Q3 2019 and held it in 8 quarters. The position peaked at $5.11M in Q2 2024. 319 funds tracked by Wall St. Rank hold AMED as of Q2 2025.

Boothbay Fund Management reported no remaining Amedisys position as of Q2 2025 after selling out during the quarter.
Boothbay Fund Management sold 3,950 Amedisys shares in Q2 2025, an estimated $366K.
Boothbay Fund Management first reported a position in Amedisys in Q3 2019 and held it in 8 quarters.
Boothbay Fund Management's Amedisys position peaked at $5.11M in Q2 2024.
319 funds tracked by Wall St. Rank held Amedisys as of Q2 2025.

Based on Boothbay Fund Management's 13F filing for Q2 2025, filed 14 Aug 2025.